symbol,statement_type,period_end,line_item,value
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,-1125403000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-1138536000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,End Cash Position,49165000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-1000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,117182000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,-68016000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,446528000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Net Other Financing Charges,1000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-1753000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,0.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,451540000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,154682000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,296858000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-527677000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,234185000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,376117000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Sale Of Investment,376117000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,0.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-1137979000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,557000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-1138536000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,13133000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,24651000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,-39279000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Liabilities,217000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Assets,23757000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Change In Payable,147890000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,60267000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,-272735000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,1753000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,10124000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,20926000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Depreciation,20926000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Pension And Employee Benefit Expense,645000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,9291000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,147000.0
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,
VALIANTLAB.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,-15126000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,-439849000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-458703000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,End Cash Position,117182000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,1000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,12616000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,104565000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,1524479000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Net Other Financing Charges,
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-778000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,1358754000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,166503000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,13875000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,152628000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-1438768000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,-944134000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,0.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,-35931000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Sale Of Investment,0.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,-35931000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-458703000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,0.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-458703000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,18854000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,9816000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,-3701000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Liabilities,-18861000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Assets,-230228000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Change In Payable,-213694000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,30270000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,428812000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,778000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,0.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,19656000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Depreciation,19656000.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Pension And Employee Benefit Expense,0.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,0.0
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,
VALIANTLAB.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,-7695000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,183702000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-376809000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,End Cash Position,12616000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,13126000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,-510000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,-9339000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Net Other Financing Charges,
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-254000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Net Common Stock Issuance,0.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,-12807000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Net Short Term Debt Issuance,-12807000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,0.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-551682000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Net Other Investing Changes,161031000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Interest Received Cfi,261000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,-336165000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Sale Of Investment,
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,-336165000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-376809000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-376809000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,560511000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-88000000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,251586000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Liabilities,-30012000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Assets,-41330000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Change In Payable,80238000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,27615000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,215075000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,-70000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Provisionand Write Offof Assets,
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,15631000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Depreciation,15631000.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Pension And Employee Benefit Expense,
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Investment Securities,
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,0.0
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,
VALIANTLAB.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,381364000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,-46250000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-68760000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,End Cash Position,1310000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,39370000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,-38060000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,61810000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Net Other Financing Charges,
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-6150000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Net Common Stock Issuance,488990000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,-420720000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Net Short Term Debt Issuance,
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,-420720000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-122380000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Net Other Investing Changes,-50000000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Interest Received Cfi,
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,-4020000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Sale Of Investment,
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,-4020000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-68360000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,400000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-68760000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,22510000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-144680000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,-280520000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Liabilities,163700000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Assets,-17540000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Change In Payable,353350000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,-97310000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,-682720000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,6150000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Provisionand Write Offof Assets,
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,24900000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Depreciation,24900000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Pension And Employee Benefit Expense,
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Investment Securities,
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,400000.0
VALIANTLAB.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,417040000.0
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-10000.0
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Net Other Financing Charges,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Net Common Stock Issuance,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Net Short Term Debt Issuance,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Net Other Investing Changes,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Interest Received Cfi,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Sale Of Investment,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,0.0
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Liabilities,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Assets,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Provisionand Write Offof Assets,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Depreciation,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Pension And Employee Benefit Expense,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Investment Securities,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,0.0
VALIANTLAB.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
